Bernadette Chevalier

Muscle development, insulin-like growth factor-I and myostatin mRNA levels in chickens selected for increased breast muscle yield.

Insulin-like growth factor-I (IGF-I) and myostatin (MSTN) are paracrine regulators of muscle growth. The present study was conducted to relate their expression with muscle fibre development in chickens selected for high breast meat yield and their controls. Both mRNA levels were measured by real-time RT-PCR in the Pectoralis major (PM) muscle between 14 days in ovo and 6 weeks post-hatch and in the Sartorius (SART) muscle between 2 and 6 weeks. The data show that PM growth was slow during in ovo development and rapid in the early post-hatch period. Chickens from the selected genotype exhibited significantly higher breast muscle yields from 2 to 6 weeks of age, and muscle fibre hypertrophy. In the PM, IGF-I and MSTN mRNA levels decreased markedly around hatch, while the IGF-I/MSTN ratio increased, suggesting that it could contribute to the explosive growth observed in the early post-hatch period. Between 4 and 6 weeks of age in selected chickens, IGF-I mRNA levels were significantly higher (p=0.04) with a similar trend in MSTN mRNA levels (p=0.07) in the PM muscle but not in the SART muscle. Our results support the hypothesis that the relative levels of IGF-I and MSTN mRNA may participate to set muscle growth rate along development, while other factors are required to explain differences between genotypes.

Muscle insulin-like growth factor-I (IGF-I) receptors in chickens with high or low body weight: effects of age and muscle fibre type.

IGF-I receptors were characterized in leg and breast muscles from 1- and 7-week-old chickens selected for high (HG) or low (LG) growth rate. Following whole muscle solubilization, receptors were partially purified by wheat germ agglutinin (WGA) chromatography. IGF-I and insulin binding did not differ between genotypes, but significantly decreased with age, without any change in receptor affinity. In the older birds, insulin binding was lower in breast than in leg muscle, whereas IGF-I binding was similar. Using the artificial substrate poly(Glu-Tyr) 4:1, the IGF-I-stimulated tyrosine kinase activity of the receptors was measured and compared between genotypes (at 1 week), and in HG chickens between muscle types (1 and 7 weeks) and ages (in leg muscle). It was not modified by any of these factors. We conclude that: (1) IGF-I and insulin receptor number do not differ between genotypes, (2) the number of both receptors decreases with age, and (3) in 7-week-old birds, breast muscle could become less responsive to insulin than leg muscles, following a decrease in receptor number.

Insulin-like growth factor-I effect on chicken hepatoma cells (LMH) is inhibited by endogenous IGF-binding proteins

LMH chicken hepatoma cells show type 1 IGF receptors and a 28 kDa IGF-binding protein (IGFBP) on their membranes. They also secrete large amounts of the 28 kDa IGFBP. Following overnight incubation in serum-free medium, human IGF-I was markedly less effective than insulin in stimulating amino acid (AIB) uptake. Chicken and human IGF-I were equipotent, consistent with their equipotency in inhibiting [125I]IGF-I binding to wheat germ agglutinin-purified IGF receptors or membrane solubilized IGFBP. When cells were supplied with fresh medium, cell-associated IGFBP were unaffected, but the level of soluble IGFBP was largely reduced. This potentiated the effect of IGF-I on AIB uptake. The effect of chicken Long-[Arg3]-IGF-I, which exhibited low affinity for the IGFBP, was unchanged. In fresh or conditioned medium, this analog was more potent than IGF-I, suggesting that both soluble and membrane-bound 28 kDa IGFBP inhibited the effect of IGF-I.